Palomino Laboratories (PALX) Income from Continuing Operations (2023 - 2025)

Palomino Laboratories has disclosed Income from Continuing Operations across 3 years of filings, most recently posting 1604885.0 for Q3 2025.

• Income from Continuing Operations for Q3 2025 came in at 1604885.0, down 1383621.55% year-over-year; the trailing twelve-month figure through Sep 2025 was 1811778.0 (down 1467.92% YoY), and the FY2024 annual result was 145866.0, down 73.78% from the prior year.
• Income from Continuing Operations came in at 1604885.0 for Q3 2025 at Palomino Laboratories, down from 43775.0 in the prior quarter.
• In the past five years, Income from Continuing Operations ranged from a high of 116.0 in Q3 2024 to a low of 1604885.0 in Q3 2025.
• The 3-year median for Income from Continuing Operations is 42863.0 (2023), against an average of 218910.44.
• Across the five-year window, Income from Continuing Operations jumped 100.27% in 2024 and tumbled 1383621.55% in 2025, its largest moves.
• Palomino Laboratories' Income from Continuing Operations stood at 32574.0 in 2023, then sank by 323.53% to 137962.0 in 2024, then slumped by 1063.28% to 1604885.0 in 2025.
• The last three Income from Continuing Operations figures came in at 1604885.0 (Q3 2025), 43775.0 (Q2 2025), and 25156.0 (Q1 2025), per Business Quant data.